Zobrazeno 1 - 8
of 8
pro vyhledávání: '"William Jonas"'
Autor:
Karnavas, William Jonas.
The tools of sensitivity analyses are old, well known, and used in diverse engineering and non-engineering fields, yet few papers include them. Perhaps this is because of the subtle tricks and customizations that have to be done to make them work. Th
Externí odkaz:
http://hdl.handle.net/10150/185883
Autor:
Yuan Liu, Amelia Zelnak, William Jonas, Andrew Pippas, Ruth O'Regan, Mylin A. Torres, Petros Nikolinakos, Jayanthi Srinivasiah, Xiaoxian Li
Publikováno v:
Clinical Breast Cancer. 15:31-36
Background Neoadjuvant chemotherapy is widely used to downstage breast cancers before surgery and is an accepted standard of care among patients with early-stage breast cancer in whom adjuvant chemotherapy would be recommended. Pathologic complete re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61349811799856e4ec8178b9740a88c3
https://doi.org/10.1016/j.clbc.2014.06.004
https://doi.org/10.1016/j.clbc.2014.06.004
Autor:
Sam L. Glover, Rafal Pawlinski, Nigel Mackman, Raj S. Kasthuri, Gowthami M. Arepally, Troy A. McEachron, William Jonas, Nigel S. Key
Publikováno v:
Blood. 119(22)
Heparin-induced thrombocytopenia (HIT) is a potentially devastating form of drug-induced thrombocytopenia that occurs in patients receiving heparin for prevention or treatment of thrombosis. Patients with HIT develop autoantibodies to the platelet fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dbbe1cb607f883c1d2bdb113ce70581
https://pubmed.ncbi.nlm.nih.gov/22653954
https://pubmed.ncbi.nlm.nih.gov/22653954
Autor:
Alan L. Porter, Andre Rogatko, Mourad Tighiouart, Fadlo R. Khuri, William Jonas, David J. Schoeneck
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(31)
Purpose Phase I clinical trials of new anticancer therapies determine suitable doses for further testing. Optimization of their design is vital in that they enroll cancer patients whose well-being is distinctly at risk. This study examines the effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1019d25839f69040f621cadbee13ad4d
https://pubmed.ncbi.nlm.nih.gov/17971597
https://pubmed.ncbi.nlm.nih.gov/17971597
Autor:
William Jonas
Publikováno v:
What Good Condition? Reflections on an Australian Aboriginal Treaty 1986–2006
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0131f4e4aa972a043f4b632f8a9f2fa
https://doi.org/10.22459/wgc.12.2006.04
https://doi.org/10.22459/wgc.12.2006.04
Autor:
Amy L. Adams, William Jonas, William C. Wood, Amelia Zelnak, Ruth O'Regan, Toncred M. Styblo, Fred Schnell, Rita Nahta, Sheryl G. A. Gabram, Jayanthi Srinivasiah, Monica Rizzo
Publikováno v:
Cancer Research. 72:2703-2703
Background: The addition of trastuzumab to preoperative chemotherapy for Her2-positive breast cancers has been shown to increase pCR rate, which correlates with improved outcome. The purpose of this study was to evaluate the efficacy of trastuzumab i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::167132627b22635b635a4e85f7d211cb
https://doi.org/10.1158/1538-7445.am2012-2703
https://doi.org/10.1158/1538-7445.am2012-2703
Autor:
Montford, William Jonas1 wjm03c@my.fsu.edu, Peloza, John2
Publikováno v:
AMA Marketing & Public Policy Academic Conference Proceedings. 2015, Vol. 25, p96-96. 1p.
Publikováno v:
The Journal of Organic Chemistry. 32:2074-2079
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab12dcff4faacf02a00a81815d611fe0
https://doi.org/10.1021/jo01282a005
https://doi.org/10.1021/jo01282a005